Practical consensus recommendations for tumor margins and breast conservative surgery

 

PDF Download Permissions and Reprints

Abstract

My suggestion: There is no difference in survival of breast cancer patients treated with either mastectomy or with breast conservation therapy combined with external beam radiotherapy. A positive margin (s) is an important factor contributing to the increased risk of local recurrence. However, in published literature, there is a lack of consensus on the definition of acceptable margin (s). As a result decision process about need for re-excision after positive margins remains uncrear.

Publication History

Article published online:
22 December 2020

© 2018. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

• References

• 1 Lacey JV Jr., Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 2002;39:82-8.
• 2 Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:37.
• 3 Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, editors. Summary of specific sites: Breast (ICD-10:C50)-females. In: Development of an Atlas of Cancer in India:First all India Report: 2001–2002. Vol. 1. Bangalore, India: National Cancer Registry Program, Indian Council for Medical Research; 2004.
• 4 Chopra R. The Indian scene. J Clin Oncol 2001;19:106S-11S.
• 5 Amr SS, Sa'di AR, Ilahi F, Sheikh SS. The spectrum of breast diseases in Saudi Arab females: A 26 year pathological survey at Dhahran health center. Ann Saudi Med 1995;15:125-32.
• 6 Breast Cancer Incidence in Different Regions GLOBOCAN 2002. IARC. Available from: http://www.dep.iarc.fr/GLOBOCAN2002.
• 7 Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT, et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-8.
• 8 Tabár L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
• 9 Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001;19:2254-62.
• 10 Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52.
• 11 Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol B-17: Intraductal carcinoma. Cancer 1999;86:429-38.
• 12 Schnitt SJ. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going? Am J Clin Pathol 2003;120:485-8.
• 13 National Cancer Registry Programme, Indian Council of Medical Research. Leading sites of cancer. In: Consolidated Report of Population Based Cancer Registries 2001-2004, Incidence and Distribution of Cancer. Bangalore: Coordinating Unit, National Cancer Registry Programme (ICMR); 2006. p. 8-30.
• 14 Badwe RA, Gangawal S, Mitra I, Desai PB. Clinico-pathological features and prognosis of breast cancer in different religious communities in India. Indian J Cancer 1990;27:220-8.
• 15 Altekruse SF, Kosary CL, Krapcho M, editors. SEER Cancer Statistics Review. National Cancer Institute; 1975-2007.
• 16 National Cancer Registry Program. Ten Year Consolidated Report of the Hospital Based Cancer Registries, 1984–1993, An Assessment of the Burden and Care of Cancer Patients. New Delhi: Indian Council of Medical Research; 2001.
• 17 Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg 2007;31:1031-40.
• 18 Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol 2014;21:704-16.
• 19 Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383-93.
• 20 Swanson GP, Rynearson K, Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 2002;25:438-41.
• 21 Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
• 22 Zavagno G, Goldin E, Mencarelli R, Capitanio G, Del Bianco P, Marconato R, et al. Role of resection margins in patients treated with breast conservation surgery. Cancer 2008;112:1923-31.
• 23 Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668-75.
• 24 Houssami N, Macaskill P, Marinovich ML, Dixon JM, Irwig L, Brennan ME, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010;46:3219-32.
• 25 Newman LA, Kuerer HM. Advances in breast conservation therapy. J Clin Oncol 2005;23:1685-97.
• 26 Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002;52:277-300.
• 27 McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, et al. Variability in reexcision following breast conservation surgery. JAMA 2012;307:467-75.
• 28 Kotwall C, Ranson M, Stiles A, Hamann MS. Relationship between initial margin status for invasive breast cancer and residual carcinoma after re-excision. Am Surg 2007;73:337-43.
• 29 Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 2008;15:1297-303.
• 30 Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Estabrook A, Smith SR, et al. The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol 2005;12:881-5.
• 31 The American Society of Breast Surgeons. Position Statement on Breast Cancer Lumpectomy Margins; 2013. Available from: https://www.breastsurgeons.org/statements/PDF_Statements/Lumpectomy_Margins.pdf. [Last accessed on 2009 Jan 28].
• 32 Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys 2014;88:553-64.
• 33 Kaufmann M, Morrow M, von Minckwitz G, Harris JR; Biedenkopf Expert Panel Members. Locoregional treatment of primary breast cancer: Consensus recommendations from an international expert panel. Cancer 2010;116:1184-91.
• 34 Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S, et al. Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey. Ann Surg 2005;241:629-39.
• 35 Young OE, Valassiadou K, Dixon M. A review of current practices in breast conservation surgery in the UK. Ann R Coll Surg Engl 2007;89:118-23.
• 36 Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW, et al. Attaining negative margins in breast-conservation operations: Is there a consensus among breast surgeons? J Am Coll Surg 2009;209:608-13.
• 37 Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 2010;17:558-63.
• 38 Morrow M. Breast conservation and negative margins: How much is enough? Breast 2009;18 Suppl 3:S84-6.
• 39 Huston TL, Pigalarga R, Osborne MP, Tousimis E. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 2006;192:509-12.
• 40 Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM, et al. Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision? Am J Surg 2008;196:556-8.
• 41 Kobbermann A, Unzeitig A, Xie XJ, Yan J, Euhus D, Peng Y, et al. Impact of routine cavity shave margins on breast cancer re-excision rates. Ann Surg Oncol 2011;18:1349-55.
• 42 Marudanayagam R, Singhal R, Tanchel B, O'Connor B, Balasubramanian B, Paterson I, et al. Effect of cavity shaving on reoperation rate following breast-conserving surgery. Breast J 2008;14:570-3.
• 43 Rizzo M, Iyengar R, Gabram SG, Park J, Birdsong G, Chandler KL, et al. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload. Ann Surg Oncol 2010;17:228-34.
• 44 Tengher-Barna I, Hequet D, Reboul-Marty J, Frassati-Biaggi A, Seince N, Rodrigues-Faure A, et al. Prevalence and predictive factors for the detection of carcinoma in cavity margin performed at the time of breast lumpectomy. Mod Pathol 2009;22:299-305.
• 45 Cao D, Lin C, Woo SH, Vang R, Tsangaris TN, Argani P, et al. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol 2005;29:1625-32.
• 46 Morrow M, Harris JR, Schnitt SJ. Surgical margins in lumpectomy for breast cancer – bigger is not better. N Engl J Med 2012;367:79-82.
• 47 Morrow M, Harris JR. Practice guideline for breast conservation therapy in the management of invasive breast cancer. J Am Coll Surg 2007;205:362-76.
• 48 Vennin P. Standards, Options and Recommendations (SOR) on hormone therapy in nonmetastatic cancer of the breast. Bull Cancer 2000;87:948-50.
• 49 Cutuli B, Fourquet A, Luporsi E, Arnould L, Caron Y, Cremoux Pd, et al. Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): Update 2004. Bull Cancer 2005;92:155-68.
• 50 Papa MZ, Zippel D, Koller M, Klein E, Chetrit A, Ari GB, et al. Positive margins of breast biopsy: Is reexcision always necessary? J Surg Oncol 1999;70:167-71.
• 51 Cellini C, Huston TL, Martins D, Christos P, Carson J, Kemper S, et al. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery. Am J Surg 2005;189:662-6.
• 52 Sabel MS, Rogers K, Griffith K, Jagsi R, Kleer CG, Diehl KA, et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol 2009;99:99-103.
• 53 Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002;9:256-65.
• 54 Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004;100:1823-32.
• 55 Huston TL, Simmons RM. Locally recurrent breast cancer after conservation therapy. Am J Surg 2005;189:229-35.
• 56 McIntosh A, Freedman G, Eisenberg D, Anderson P. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol 2007;30:146-51.
• 57 Ciocca RM, Li T, Freedman GM, Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008;15:2263-71.
• 58 Schwentner L, Helms G, Nekljudova V, Ataseven B, Bauerfeind I, Ditsch N, et al. Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy – Results from the multi-center SENTINA trial. Breast 2017;31:202-7.
• 59 Zetterlund LH, Frisell J, Zouzos A, Axelsson R, Hatschek T, de Boniface J, et al. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer. Breast Cancer Res Treat 2017;163:103-10.